190 related articles for article (PubMed ID: 19137541)
1. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells.
Rizzi F; Caccamo AE; Belloni L; Bettuzzi S
J Cell Physiol; 2009 May; 219(2):314-23. PubMed ID: 19137541
[TBL] [Abstract][Full Text] [Related]
2. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
3. Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity.
Turkieh A; Porouchani S; Beseme O; Chwastyniak M; Amouyel P; Lamblin N; Balligand JL; Bauters C; Pinet F
Cell Death Dis; 2019 Aug; 10(8):608. PubMed ID: 31406108
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor-1α directly regulates nuclear clusterin transcription by interacting with hypoxia response elements in the clusterin promoter.
Park J; Park SY; Shin E; Lee SH; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kim H; Choi WS
Mol Cells; 2014 Feb; 37(2):178-86. PubMed ID: 24599003
[TBL] [Abstract][Full Text] [Related]
5. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
Li N; Zoubeidi A; Beraldi E; Gleave ME
Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
[TBL] [Abstract][Full Text] [Related]
6. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
[TBL] [Abstract][Full Text] [Related]
7. CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.
Leskov KS; Araki S; Lavik JP; Gomez JA; Gama V; Gonos ES; Trougakos IP; Matsuyama S; Boothman DA
J Biol Chem; 2011 Nov; 286(46):40083-90. PubMed ID: 21953454
[TBL] [Abstract][Full Text] [Related]
8. Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability.
Matsumoto H; Yamamoto Y; Shiota M; Kuruma H; Beraldi E; Matsuyama H; Zoubeidi A; Gleave M
Cancer Res; 2013 Aug; 73(16):5206-17. PubMed ID: 23786771
[TBL] [Abstract][Full Text] [Related]
9. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.
Shannan B; Seifert M; Leskov K; Willis J; Boothman D; Tilgen W; Reichrath J
Cell Death Differ; 2006 Jan; 13(1):12-9. PubMed ID: 16179938
[TBL] [Abstract][Full Text] [Related]
10. siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer.
Yamamoto Y; Lin PJ; Beraldi E; Zhang F; Kawai Y; Leong J; Katsumi H; Fazli L; Fraser R; Cullis PR; Gleave M
Clin Cancer Res; 2015 Nov; 21(21):4845-55. PubMed ID: 26106075
[TBL] [Abstract][Full Text] [Related]
11. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
[TBL] [Abstract][Full Text] [Related]
12. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
[TBL] [Abstract][Full Text] [Related]
13. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
[TBL] [Abstract][Full Text] [Related]
14. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A
Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631
[TBL] [Abstract][Full Text] [Related]
15. Targeting Clusterin in prostate cancer.
Rizzi F; Bettuzzi S
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():265-74. PubMed ID: 19261985
[TBL] [Abstract][Full Text] [Related]
16. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress.
Trougakos IP; So A; Jansen B; Gleave ME; Gonos ES
Cancer Res; 2004 Mar; 64(5):1834-42. PubMed ID: 14996747
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the expression of CLU isoforms in endometrial proliferative diseases.
Fuzio P; Valletti A; Napoli A; Napoli G; Cormio G; Selvaggi L; Liuni S; Pesole G; Maiorano E; Perlino E
Int J Oncol; 2013 Jun; 42(6):1929-44. PubMed ID: 23589125
[TBL] [Abstract][Full Text] [Related]
18. The clusterin paradigm in prostate and breast carcinogenesis.
Rizzi F; Bettuzzi S
Endocr Relat Cancer; 2010 Mar; 17(1):R1-17. PubMed ID: 19903745
[TBL] [Abstract][Full Text] [Related]
19. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
[TBL] [Abstract][Full Text] [Related]
20. Chapter 4: Regulation of Clusterin activity by calcium.
Pajak B; Orzechowski A
Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]